{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Rad Chat","title":"Bonus Episode: Dr. Veronica Dell’Acqua and Prof. Cihan Gani - Hypothesis Testing Programme and MR-Adaptive Dose Escalated Radiotherapy in Rectal Cancer","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ce21054e\"></iframe>","width":"100%","height":180,"duration":2056,"description":"Naman Julka-Anderson and Jo McNamara catch up with Dr. Veronica Dell’Acqua and Prof. Cihan Gani about incredible careers, the hypothesis testing programme (HTP) and MR-adaptive dose escalated radiotherapy in rectal cancer (MARS).\n \nTo use this podcast as CPD, look at these reflection points: \n1) consider the benefits of the MR Linac consortium in progressing MR-adaptive radiotherapy.\n2) reflect on the challenges people with rectal cancer face with current radiotherapy workflows.\n3) consider the benefits of organ sparing within the rectal cancer pathway.\n\nComplete this form for your accredited digital badge: https://bit.ly/3GbtR1X.\n\nLinks from podcast:\nMR-Linac Consortium Website: https://mrlconsortium.org\nElekta Focus Article on MR Linac: https://www.elekta.com/focus/first-of-its-kind-program-to-reinforce-mr-guided-radiation-therapy-evidence-base/\nEvolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac: https://www.redjournal.org/article/S0360-3016(23)06346-0/fulltext\nOutcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05415-9/fulltext\nPatient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05720-6/fulltext\nOptimising the MR-Linac as a standard treatment modality: https://onlinelibrary.wiley.com/doi/10.1002/jmrs.712\nInterim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy: https://www.redjournal.org/article/S0360-3016(23)07949-X/fulltext\nDevelopment of prostate bed delineation consensus guidelines for MRI-guided radiotherapy and assessment of its impact on interobserver variability: https://www.redjournal.org/article/S0360-3016(23)07848-3/fulltext\nGating and...","thumbnail_url":"https://img.transistorcdn.com/0wFiffqRab_C_nPB5bCBJUg_mULsM2eF_DxRLoq0kVA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xZDE3/OGQ3YjY4OTE4Yjkz/ZmQzNTJhNDlkYmQz/OTY3ZC5KUEc.webp","thumbnail_width":300,"thumbnail_height":300}